Radiopharm Theranostics RADX Income Statement (2023-2026)

NASDAQ RADX
$0.88 -0.07 (-7.70%)
At close: Nov 9, 2026 · 4:00 PM EST
Reported Financials

Radiopharm Theranostics Quarterly Income Statement

Periods 5 quarters
Latest Jun 2026

Radiopharm Theranostics income statement data for the quarter ended Jun 2026. This income statement covers 5 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Jun2023 Jun2024 Dec2024 Jun2025 Jun2026
Non-operating items
Other Non Operating IncomeOther Non Op Inc. -0.26M
Net income details
Net Income Attributable to Noncontrolling InterestsNCI Net Income -0.16M
Additional items
Shares Outstanding 1.02M1.29M1.29M6.94M10.24M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 1.02M1.29M1.29M6.94M10.24M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 1.02M1.29M7.88M11.81M

Radiopharm Theranostics Income Statement API

Pull Radiopharm Theranostics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RADX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY